Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
about
Combined hepatocellular cholangiocarcinoma: Controversies to be addressedReview to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinomaInvolvement of inflammation and its related microRNAs in hepatocellular carcinomaAging-associated oxidative stress inhibits liver progenitor cell activation in mice.Proliferative ductular reactions correlate with hepatic progenitor cell and predict recurrence in HCC patients after curative resection.Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients.Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma.CD44 expression in patients with combined hepatocellular cholangiocarcinoma.Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma.Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinomaPrognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks.Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases.Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma.Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers.Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.The effect of hepatic progenitor cells on experimental hepatocellular carcinoma in the regenerating liver.The diversity and plasticity of adult hepatic progenitor cells and their niche.Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma.Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma.Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis.Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor
P2860
Q26749446-CE919BF0-7B75-46B8-BBC6-404D8ADA0403Q26852680-656E737C-A216-48EC-ADE0-E2FB73BDC171Q28079138-EA27C7B6-4411-4C0D-9DE7-E0DCC3743028Q33804576-8DBD20F2-1DC6-4393-B038-D472AE1448FCQ34143795-46899DB2-4C23-4A6A-96AC-EEEC36BB6887Q34667817-41E224D3-01AE-4A12-AC80-82DEA714907AQ35058487-809626E1-1530-4934-AEDC-73FFFC25DC70Q35782494-2D4F98BB-F6EE-420D-90D9-150E9A083E52Q35999457-7FC4D741-F94A-4372-8877-A10F34203937Q36070832-3D70FBD6-0A9F-441C-9CCA-1B3793C34794Q36233866-D018EDB9-DC3C-412D-A487-47983DE424A9Q36619079-51988564-E221-4DB4-BE35-19A67FCD3324Q37291238-CB6D483A-A04A-458B-B5BC-B93898A22C94Q37584658-E1B27490-988F-46FE-8BB9-C19F06FFF19AQ37675494-D135912E-0CB0-4F86-9272-50C2CBCC3905Q38155513-D1E4BD73-AB46-48A5-87E5-E2859A79E7A8Q38962085-A55D3B0B-22E7-413E-B35B-1780FB36AAA3Q39016627-A0913896-5D4B-413F-B189-E944D0FF9BCBQ39067349-CD64DE58-EC04-44DE-821E-1A30F85823AAQ39109678-E616DD21-F593-43F1-AA4A-3E48E5D5E831Q51751398-5DF4E30E-F699-45F0-BC4C-30E348AB859CQ52655169-B5192451-5D50-4993-A413-683D858FE307Q55249804-F615A878-3FD3-4FE3-9C2D-9180BC1F73C1Q55359727-0E5850F5-25D0-4D5D-A12B-1F0129BD7A03Q57150951-CA13C199-F5BA-45EF-A7BB-C2A2EBD3701C
P2860
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Background progenitor activati ...... tocellular-cholangiocarcinoma.
@ast
Background progenitor activati ...... tocellular-cholangiocarcinoma.
@en
type
label
Background progenitor activati ...... tocellular-cholangiocarcinoma.
@ast
Background progenitor activati ...... tocellular-cholangiocarcinoma.
@en
prefLabel
Background progenitor activati ...... tocellular-cholangiocarcinoma.
@ast
Background progenitor activati ...... tocellular-cholangiocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Background progenitor activati ...... tocellular-cholangiocarcinoma.
@en
P2093
David E Kaplan
Guangyang Qian
Lining Zhou
Mengchao Wu
P2860
P304
P356
10.1002/HEP.25874
P407
P577
2012-06-25T00:00:00Z